Cargando…
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
The epidermal growth factor receptor (EGFR) family contains four transmembrane tyrosine kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted polypeptide ligands. EGFRs are overexpressed in many solid tumors, including breast, pancreas, head-and-neck, prostate, ovarian, renal,...
Autores principales: | Maennling, Amaia Eleonora, Tur, Mehmet Kemal, Niebert, Marcus, Klockenbring, Torsten, Zeppernick, Felix, Gattenlöhner, Stefan, Meinhold-Heerlein, Ivo, Hussain, Ahmad Fawzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966464/ https://www.ncbi.nlm.nih.gov/pubmed/31756933 http://dx.doi.org/10.3390/cancers11121826 |
Ejemplares similares
-
EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment
por: Zhang, Chaoyu, et al.
Publicado: (2022) -
Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras
por: Nachreiner, Inga, et al.
Publicado: (2019) -
Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy
por: Mohiuddin, T. M., et al.
Publicado: (2023) -
Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy
por: Sheng, Wenjie, et al.
Publicado: (2023) -
Prevention of Intraoperative Hypothermia in Laparoscopy by the Use of Body-Temperature and Humidified CO
(2)
: a Pilot Study
por: Wittenborn, Julia, et al.
Publicado: (2019)